Fiduciary Trust’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$381K Buy
13,633
+3
+0% +$84 ﹤0.01% 676
2026
Q1
$389K Buy
13,630
+1,824
+15% +$62.2K ﹤0.01% 661
2025
Q4
$467K Buy
11,806
+2,303
+24% +$84.4K 0.01% 584
2025
Q3
$335K Hold
9,503
﹤0.01% 667
2025
Q2
$311K Buy
9,503
+650
+7% +$21.1K ﹤0.01% 672
2025
Q1
$286K Buy
+8,853
New +$329K ﹤0.01% 678

Other funds holding ATRC

Fiduciary Trust's ATRC Position: Q2 2026 in Review

Fiduciary Trust increased its AtriCure (ATRC) stake by 0.02% in Q2 2026, buying an estimated $84 and bringing the position to 13,633 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #676.

Fiduciary Trust first reported a position in ATRC in Q1 2025 and has held it in 6 quarters since. The position peaked at $467K in Q4 2025. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Fiduciary Trust held 13,633 shares of AtriCure worth $381K as of Q2 2026.
  • Fiduciary Trust bought 3 AtriCure shares in Q2 2026, an estimated $84.
  • AtriCure made up ﹤0.01% of Fiduciary Trust's portfolio in Q2 2026, its #676 holding.
  • Fiduciary Trust first reported a position in AtriCure in Q1 2025 and has held it in 6 quarters since.
  • Fiduciary Trust's AtriCure position peaked at $467K in Q4 2025.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.